logo
Deodorant recalled: Why FDA recalled 67,000 cases of Power Stick deodorants sold at Walmart, Dollar Tree, and Amazon

Deodorant recalled: Why FDA recalled 67,000 cases of Power Stick deodorants sold at Walmart, Dollar Tree, and Amazon

Time of India7 days ago
After blueberries, Greek yogurt, chocolates, and even water bottles, the FDA is now recalling deodorants!
The Food and Drug Administration (FDA) has issued a voluntary recall of over 67,000 cases of Power Stick roll‑on deodorants manufactured by A.P.
Deauville. The recall, which was announced on July 10, covers three popular variants – Power Stick for Her 'Power Fresh', Invisible Protection 'Spring Fresh', and Original Nourishing Invisible Protection.
These products were sold widely through Walmart, Dollar Tree, and Amazon, affecting consumers across the United States. The recall was reportedly triggered by deviations from the FDA's Current Good Manufacturing Practices (cGMP), a red flag for production oversight and quality control, although no contamination was reported.
Read on to know more.
What caused the recall?
On July 10, A.P. Deauville initiated the recall of 67,214 combined cases of Power Stick deodorant sold nationwide.
For the recall, the FDA enforcement reported cGMP deviations, which listed failures in adhering to current good manufacturing practices as the primary reason. The FDA strictly enforces cGMP regulations to ensure products are consistently produced with accurate ingredients, proper strength, and no contamination.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Do you have a mouse?
Desert Order
Undo
These regulations ensure that products are consistently manufactured in controlled environments, maintaining quality, safety, and efficacy.
However, it is important to note that no harmful substance was found in those products. cGMP issues, although do not always indicate direct harm, any breach in manufacturing protocols – be it equipment calibration, hygiene, ingredient verification, or documentation control – can compromise product integrity, making this recall a critical decision.
Why
cGMP compliance
matters
Current Good Manufacturing Practices (cGMP) form a regulatory backbone ensuring that mass‑produced items, from medications to deodorants, meet rigorous safety and quality benchmarks. When deviations occur, whether in cleanliness, equipment calibration, or ingredient testing, consumer safety can't be guaranteed, even if no immediate harm is reported.
Even in the absence of direct harm, any cGMP lapse poses potential quality risks, hence the proactive recall.
Which items were recalled
The recall includes three 1.8-oz roll‑on deodorants, each with specific lot numbers:
Power Stick for Her Roll‑On 'Power Fresh'
– 21,265 cases, e.g., lots 032026B011, 071226D381, 082826E402.
Power Stick Invisible Protection 'Spring Fresh' Roll‑On
– 22,482 cases, e.g., 031726A991, 071026D361, 111626G231.
Power Stick Original Nourishing Invisible Protection
– 23,467 cases, e.g., 032826B221, 070626D301, 111626G221.
These Power Stick variants were sold nationwide via:
Walmart
– 3‑packs sold at around $21
Dollar Tree
– 24‑packs for about $30
Amazon
– available as individual or multi‑packs
Consumers who purchased from any of these retailers are urged to inspect the UPC/barcode on the packaging, match the lot numbers printed beneath to see if their purchase is affected, and discontinue use if their deodorant is part of the recall.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Low insurance costs, affordable treatment and medicines drawing NRIs to India
Low insurance costs, affordable treatment and medicines drawing NRIs to India

Time of India

time10 hours ago

  • Time of India

Low insurance costs, affordable treatment and medicines drawing NRIs to India

While treatment costs in India are low, so are the medical insurance premiums. (AI image) New Delhi: Low medical insurance premiums, affordable treatment costs and high quality healthcare facilities at private hospitals are making NRIs turn to India for medical treatment, according to a report by Policybazaar. The insurance aggregator noted that the share of NRI buyers of health insurance grew 150% in 2024-25 as compared to the previous year. One of India's most compelling advantages is the dramatic cost difference for medical procedures. Healthcare costs in India are very low compared to what one pays in the US and other developed countries. Patients can save 60-90% on treatments in India. To give you a perspective, here's a comparison of the costs of some surgical procedures in the two countries. Figures are indicative and actual costs may vary depending on the hospital chosen and the location. Treatment Cost in the US Cost in India Heart bypass surgery Rs 60 lakh to Rs 1.3 crore Rs 4.5 lakh to Rs 8 lakh Knee replacement Rs 25 lakh to Rs 45 lakh Rs 3.5 lakh to Rs 5 lakh Liver transplant Rs 2.5 crore to Rs 4 crore Rs 21 lakh to Rs 30 lakh Kidney transplant Rs 1.7 crore to Rs 2.6 crore Rs 6 lakh to Rs 10 lakh *US figures converted to rupees at Rs 86.5 per dollar. Source: Policybazaar While treatment costs in India are low, so are the medical insurance premiums compared to what one pays in the US and other countries. The average annual health insurance premium per person in India is $120-300 (Rs 10,000-26,000), which is significantly lower than $8,000 (Rs 6.9 lakh) payable in the US or $4,000-5,000 (Rs 3.4-4.3 lakh) charged in GCC countries. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Walmart Cameras Captured These Hilarious 20 Photos Undo This has led many NRIS to purchase health cover from insurance companies in India. Policybazaar has also noted a surge in online queries from NRIs expressing interest to buy health insurance in India. According to Google Trends and industry search data, queries like 'Best health insurance plans for parents in India' consistently ranks among the top 5 NRI-related insurance searches from the UAE, UK, and US markets. What's more, even medicines in India are significantly cheaper. For example, a vial of insulin costs Rs 85-400 in India versus Rs 8,600-25,000 in the US. The cost of medicines can add up to a huge amount, but insurance helps cover these at low costs. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now

State FDA issues notice to eway outlet of Cafe Goodluck, revokes suspension of FC Road branch
State FDA issues notice to eway outlet of Cafe Goodluck, revokes suspension of FC Road branch

Time of India

timea day ago

  • Time of India

State FDA issues notice to eway outlet of Cafe Goodluck, revokes suspension of FC Road branch

Pune: The state Food & Drug Administration on Friday issued a notice to the expressway outlet of Cafe Goodluck after finding some hygiene issues. FDA officials conducted an inspection at the outlet after a customer allegedly found a dead cockroach in an egg bhurji. Tired of too many ads? go ad free now "Based on initial inspection, we collected food samples from the outlet and sent them for testing at our labs. We have asked them to furnish mandatory pest control records from the past, and internal, external audit reports," said Milind Mahangade, assistant commissioner, FDA, Raigad division. The outlet continues to be operational for now. The cafe management was not reachable when contacted. Meanwhile, the FDA has revoked the suspension of the FC Road outlet of the cafe after a re-inspection. Earlier this month, the Pune FDA had suspended the licence of the outlet after a glass piece was allegedly found in a bun maska. Suresh Annapure, joint commissioner, FDA (Pune), said, "Based on the re-inspection of Cafe Goodluck at FC Road, we have decided to revoke the licence suspension as they are compliant now with all the standards as per Schedule 4 of the Food Safety and Standards Act."

Tuna salad recalled in US: Listeria alert hits 7 states; full list of affected regions
Tuna salad recalled in US: Listeria alert hits 7 states; full list of affected regions

Time of India

timea day ago

  • Time of India

Tuna salad recalled in US: Listeria alert hits 7 states; full list of affected regions

Represntational AI image Grocery stores across seven US states have pulled tuna salad items off their shelves after fears of listeria contamination. The recall, announced by the US food and drug administration (FDA) on Monday, was linked to products supplied by Reser's Fine Foods. The contamination was traced to breadcrumbs used in the tuna salads. No cases of illness have been reported so far. The affected items include sandwiches, croissants, snack packs and salad trays sold in Jewel-Osco outlets in Illinois, Indiana and Iowa, and in Albertsons, Randalls and Tom Thumb stores in Arkansas, Louisiana, Oklahoma and Texas. All the products have specific sell-by dates between 16 and 19 July. Customers have been advised to throw away or return recalled items for a full refund. What is Listeria Listeria is a bacteria that can cause severe illness, especially in pregnant people, the elderly, children and those with low immunity. The infection may lead to fever, nausea, diarrhoea or, in serious cases, miscarriage or stillbirth. The FDA has also asked people to clean all surfaces that may have come into contact with the products, warning that listeria can survive in cold storage like refrigerators.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store